Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Semi Equipment Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Donald Wennerstrom who wrote (872)	7/28/2001 5:28:30 PM
From: Will Lyons	Respond to of 95456

Hi David I notice you do have two listed stocks WFR and TER as well as one under $5 [TGAL] in your very valuable tables. But you do not have any listed AND under $5! May I respectfully suggest a look at CVD Equipment on the AMEX [CVV] for a possible blood transfusion! See my post 10006 on SEMI EQUIPS-buy when blood is running in the streets. CVV has a lower p/e than any on your list, is earning a profit, and a backlog triple last year and coming out with earnings in about two weeks--that should beat TER JDSU KLIC NT XRX CSCO ANAD ASYT and many others, not only collectibvely but also individually! Coomments and/or criticisms welcome WL

To: Donald Wennerstrom who wrote (872)	7/28/2001 5:31:11 PM
From: Will Lyons	Read Replies (1) \| Respond to of 95456

Hi Donald I notice you do have two listed stocks WFR and TER as well as one under $5 [TGAL] in your very valuable tables. But you do not have any listed AND under $5! May I respectfully suggest a look at CVD Equipment on the AMEX [CVV] for a possible blood transfusion! See my post 10006 on SEMI EQUIPS-buy when blood is running in the streets. CVV has a lower p/e than any on your list, is earning a profit, and a backlog triple last year and coming out with earnings in about two weeks--that should beat TER JDSU KLIC NT XRX CSCO ANAD ASYT and many others, not only collectibvely but also individually! Coomments and/or criticisms welcome WL